Business, energy, technology, markets and global industry news from Business News Today

National Health Service

PharmaDeviceNews National Health Service
Representative image: A clinician uses a handheld skin assessment device, reflecting DermaSensor’s CE Mark and the growing role of AI-assisted skin cancer triage in European primary care.
Pharma & Biotech

Could DermaSensor’s NHS study turn AI skin cancer tools into primary care infrastructure?

Find out how DermaSensor’s CE Mark and NHS study could reshape AI-assisted skin cancer assessment across European primary care.

Read More
Representative image of an oncology consultation as Imfinzi moves toward becoming the first NHS immunotherapy option for eligible stomach cancer patients in England, marking a potential shift in gastric cancer treatment pathways.
Pharma & Biotech

AstraZeneca’s Imfinzi becomes first NHS immunotherapy for operable stomach cancer

Stomach cancer care gains immunotherapy, but NHS adoption now depends on surgery timing, toxicity management and recurrence data.

Read More